Related Experiment Videos
Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor
M Ellaurie1, E R Burns, A Rubinstein
1Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY.
Insights
Anemia, leukopenia, and thrombocytopenia are common in symptomatic children with human immunodeficiency virus (HIV) infection, significantly predicting disease progression and mortality. Passively acquired maternal antibodies did not suppress hematopoiesis.
Area of Science:
- Pediatrics
- Hematology
- Infectious Diseases
Background:
- Symptomatic children with human immunodeficiency virus (HIV) infection often exhibit hematologic abnormalities.
- Understanding these hematologic changes is crucial for predicting disease progression and outcomes in pediatric HIV.
- Comparison groups included HIV-uninfected infants with maternal anti-HIV antibodies and those born to HIV-uninfected mothers with a history of intravenous drug abuse.
Purpose of the Study:
- To evaluate the hematologic profile of symptomatic children infected with HIV.
- To compare the hematologic findings in HIV-infected children with those in control groups.
- To determine the relationship between hematologic parameters and disease progression in pediatric HIV.
Main Methods:
- Hematologic profiles of 100 symptomatic HIV-infected children were assessed.
- Comparison was made with HIV-uninfected infants (controls).
- Hematocrit (HcT) levels were analyzed in relation to disease course.
Main Results:
- Anemia was prevalent in 94% of HIV-infected infants, serving as a key predictor of disease progression.
- A hematocrit below 25% was associated with a rapidly fatal outcome in 91% of patients.
- Leukopenia (47%) and thrombocytopenia (33%) were observed, with neutropenia most severe in those with opportunistic infections.
Conclusions:
- Hematologic abnormalities, particularly anemia, are significant indicators of disease severity and prognosis in pediatric HIV infection.
- The study found no evidence that passively acquired maternal anti-HIV antibodies suppress hematopoiesis in infants.
- These findings underscore the importance of monitoring hematologic parameters in the management of pediatric HIV.
Abstract:
The hematologic profile of 100 symptomatic children infected by the human immunodeficiency virus (HIV) was evaluated and compared to HIV uninfected infants with transplacentally acquired maternal anti-HIV antibodies, and to HIV-negative infants born to i.v. drug-abusing HIV uninfected mothers. Anemia was present in 94% of HIV-infected infants and was a major predictor of disease progression. In 91% of patients having a hematocrit (HcT) less than 25%, the disease course was rapidly fatal. Leukopenia and thrombocytopenia occurred in 47 and 33% of HIV infected patients, respectively. Neutropenia was most severe in children with opportunistic infections. There was no evidence of suppression of any component of hematopoiesis by passively acquired antibodies to HIV.